Table S1 from Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects Article Swipe

Alexandria P. Eiken , Audrey L. Smith , Sydney A. Skupa , Elizabeth Schmitz , Sandeep Rana , Sarbjit Singh , Siddhartha Kumar , Jayapal Reddy Mallareddy , Aguirre A. de Cubas , Akshay Krishna , Achyuth Kalluchi , M. Jordan Rowley , Christopher R. D’Angelo , Matthew A. Lunning , R. Gregory Bociek , Julie M. Vose , Amarnath Natarajan , Dalia El‐Gamal · YOU? · · 2024 · Open Access · · DOI: https://doi.org/10.1158/2767-9764.25880252 · OA: W4398204072